Search Results - Alice Tsai

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review

    Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review by Charlotte L. Deijen, Alice Tsai, T. W. A. Koedam, M. Veltcamp Helbach, Colin Sietses, Antonio M. Lacy, H. Jaap Bonjer, Jurriaan B. Tuynman

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer

    COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer by Charlotte L. Deijen, Simone Velthuis, Alice Tsai, Stella Mavroveli, Elly S.M. de Lange–de Klerk, Colin Sietses, Jurriaan B. Tuynman, Antonio M. Lacy, George B. Hanna, H. Jaap Bonjer

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion

    Discovery of TNG462: A Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitor to Target Cancers with <i>MTAP</i> Deletion by Kevin M. Cottrell, Kimberly J. Briggs, Alice Tsai, Matthew R. Tonini, Douglas A. Whittington, Shanzhong Gong, Colin Liang, Patrick McCarren, Minjie Zhang, Wenhai Zhang, Alan Huang, John P. Maxwell

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers

    TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers by Kimberly J. Briggs, Kevin M. Cottrell, Matthew R. Tonini, Alice Tsai, Minjie Zhang, Douglas A. Whittington, Wenhai Zhang, Steven A. Lombardo, Satoshi Yoda, Erik Wilker, Samuel R. Meier, Yi Yu, Teng Teng, Alan Huang, John P. Maxwell

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective

    Physiologically‐Based Pharmacokinetic Modeling in Renal and Hepatic Impairment Populations: A Pharmaceutical Industry Perspective by Tycho Heimbach, Yuan Chen, Jun Chen, Vaishali Dixit, Neil Parrott, Sheila Annie Peters, Italo Poggesi, Pradeep Sharma, Jan Snoeys, Mohamad Shebley, Guoying Tai, Susanna Tse, Vijay Upreti, Ying‐Hong Wang, Alice Tsai, Binfeng Xia, Ming Zheng, Andy Z. X. Zhu, Stephen D. Hall

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers

    Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted Cancers by Kevin M. Cottrell, Kimberly J. Briggs, Douglas A. Whittington, Haris Jahić, Janid A. Ali, Charles B. Davis, Shanzhong Gong, Deepali Gotur, Lina Gu, Patrick McCarren, Matthew R. Tonini, Alice Tsai, Erik Wilker, Hongling Yuan, Minjie Zhang, Wenhai Zhang, Alan Huang, John P. Maxwell

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit

    Preclinical Activity of VX-787, a First-in-Class, Orally Bioavailable Inhibitor of the Influenza Virus Polymerase PB2 Subunit by Randal A. Byrn, Steven J.M. Jones, Hamilton B. Bennett, Chris Bral, Michael P. Clark, Marc Jacobs, Ann D. Kwong, Mark W. Ledeboer, Joshua R. Leeman, Colleen F. McNeil, Mark A. Murcko, Azin Nezami, Emanuele Perola, René Rijnbrand, Kumkum Saxena, Alice Tsai, Yi Zhou, Paul S. Charifson

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza

    Novel 2-Substituted 7-Azaindole and 7-Azaindazole Analogues as Potential Antiviral Agents for the Treatment of Influenza by Upul K. Bandarage, Michael P. Clark, Emanuele Perola, Huai Gao, Marc Jacobs, Alice Tsai, Jeffery Gillespie, Joseph M. Kennedy, François Maltais, Mark W. Ledeboer, Ioana Davies, Wenxin Gu, Randal A. Byrn, Kwame Nti Addae, Hamilton B. Bennett, Joshua R. Leeman, Steven M. Jones, Colleen O’Brien, Christine Memmott, Youssef L. Bennani, Paul S. Charifson

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: